Hicks Thermometers India Unlisted Share

₹1999

*Average Price as per 8 May, 2024

company-logo

Fundamentals

FACE VALUE

10

BOOK VALUE

1069.33

NO OF SHARES

329540

EPS

70.33

SALES

45.22

INDUSTRY PE

75.79

DIVIDEND

0

DIVIDEND YIELD

0

PE

24.16

PB

1.59

PS

1.24

MARKET CAP

55.99

EQUITY

0.33

PAT

2.11

MESSAGE

2022-23

OVERVIEW

Hicks Thermometers India Ltd have a wide marketing network of over 1500 distributors in various states of India. Moreover, we have distribution offices at Delhi, Kolkata, Patna, Jaipur, Nagpur, Mumbai, Guwahati and Chennai along with a marketing team to provide these products to various outlets regularly. This excellent marketing facility also enables us to furnish bulk amount of products effectively and timely.
They have a very strong client base which are well known in this industry. It is the efficient working approach and high customer satisfaction that provides Hicks a rich dividend in terms of a vast global clientèle. Several renowned institution have vested their interests in them. These institutions are :
  • Apollo Hospital
  • Escort Hospital
  • Cadila Pharmaceutical
  • Ranbaxy Laboratories
  • Dr. Reddy's Laboratories
  • Glaxo and many more. 

Products Range:-
Thermometers
Healthcare products
Diagnostic Products
Medical Instruments


INSIGHT

During the financial year 2021-22, the Company recorded revenue from operations of Rs. 91.49 Cr. and Profit Before Tax of R 9.80 Cr. and Net Profit of Rs.7.26 Cr. as against that of    Rs.68.71 Cr, Rs.7.36 Cr.and Rs.5.49 Cr. respectively in the previous financial year 2020-21. The company has recorded the immense growth in the revenue of the company at looking forward for the further growth in the next coming year. The Company does not propose to transfer any amount to the General Reserve out of the amount available for appropriations. In order to conserve the resources of the company, the Board of Directors have decided not to declare any dividend

SECONDARY NAME

Hicks Thermometers India Unlisted Share

ISIN

INE923S01017

CDSL

Yes

NSDL

No

INDUSTRY

Healthcare

SECTOR (READ ONLY)

Medical equipment

SHARE HOLDINGS

Name of ShareholderHoldings
Hari Prakash Gupta26.51 %
Siddhart Gupta28.23 %
Kusum Gupta9.34 %
Other35.92 %
Founders

NRIs invest Before IPO via SB NRI

We're different. SB NRI is the first of it's kind platform built for NRIs offering digital Investment plans.

Schedule a Call

Trusted by 1,000s of NRIs spread across the Globe

One-stop Platform for NRI

Making NRI lives easier by solving Banking, Investment, Tax & all other India related needs. Download SBNRI